Literature DB >> 22953500

IgG4-related disease.

K Hirabayashi1, G Zamboni.   

Abstract

IgG4-related disease (IgG4-RD) is considered a fibro-inflammatory condition with a marked propensity to form mass forming lesions, characterized by a dense lymphoplasmacytic infiltrate, the presence of abundant IgG4+ plasma cells, frequent elevation of serum IgG4 and a dramatic initial response to glucocorticoid. Nowadays, IgG4-RD has been described in almost every organ system: the pancreatobiliary tract, liver, salivary glands, nasopharynx, bone marrow, lacrimal gland, extra-ocular muscles and retrobulbar space, kidneys, lungs, lymph nodes, meninges, aorta and arteries, skin, breast, prostate, thyroid gland and pericardium. Although the common diagnostic features of all these regional involvements cannot be defined with certainty, and slight differences have been noted in different organs, many histopathological features are shared. Consensus has not yet been reached regarding criteria that have to be fulfilled for a new IgG4-RD. The proposed criteria include appropriate clinical and histopathological findings, presence of abundant tissue-infiltrating IgG4+ plasma cells, high serum IgG4 concentrations, response to steroid therapy, other autoimmune diseases or other organ involvement. The two hallmark features for diagnosis are histopathological characteristics and the presence of infiltrating IgG4+ plasma cells. In this review, we will focus on the histopathological features of IgG4-RD in specific organs and discuss the relationship with inflammatory pseudotumour and malignancy, IgG4 counting methods, and diagnosis using biopsy specimens. IgG4-related disease (IgG4-RD) is a multi-organ system disease that has been recognized in the last 10 years. IgG4-RD has a marked propensity to present as mass-forming lesions. The two hallmark features for diagnosis are histopathological characteristics and the presence of infiltrating IgG4+ plasma cells. Correct identification is crucial to avoid unnecessary major surgical procedures and initiate corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22953500

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  8 in total

Review 1.  Inflammatory myofibroblastic tumors of the head and nec.

Authors:  Jiang Tao; Min-Li Zhou; Shui-Hong Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  IgG4-related multiorgan disease: report of the first autopsy case.

Authors:  Minerva Lazos Ochoa; Belem Gabiño López; Raúl Romero Cabello; Raúl Romero Feregrino
Journal:  BMJ Case Rep       Date:  2013-05-02

Review 3.  [IgG4-related disease].

Authors:  J Loock; B Manger
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

4.  Clinical research on benign lymphoepithelial lesions of lacrimal gland in 20 Chinese patients.

Authors:  Jian-Min Ma; Jing Li; Xin Ge; Ming Li; Jin-Ru Li; Xiao-Na Wang
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

Review 5.  Diagnosis and Treatment of Acute Pancreatitis.

Authors:  Julia Walkowska; Nicol Zielinska; R Shane Tubbs; Michał Podgórski; Justyna Dłubek-Ruxer; Łukasz Olewnik
Journal:  Diagnostics (Basel)       Date:  2022-08-15

Review 6.  The Pancreas and Known Factors of Acute Pancreatitis.

Authors:  Julia Walkowska; Nicol Zielinska; Piotr Karauda; R Shane Tubbs; Konrad Kurtys; Łukasz Olewnik
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

Review 7.  Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects.

Authors:  Giuseppe Bellastella; Maria Ida Maiorino; Antonio Bizzarro; Dario Giugliano; Katherine Esposito; Antonio Bellastella; Annamaria De Bellis
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

Review 8.  Inflammatory and tumor-like lesions of the pancreas.

Authors:  Claudio Luchini; Matteo Fassan; Claudio Doglioni; Paola Capelli; Giuseppe Ingravallo; Giuseppina Renzulli; Sara Pecori; Gaetano Paolino; Ada M Florena; Aldo Scarpa; Giuseppe Zamboni
Journal:  Pathologica       Date:  2020-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.